Koninklijke Philips NV

Análisis de la acción Koninklijke Philips NV (PHG)

$25.740

+0.252 (+0.98%)Al cierre

Loading chart…
Máximo
26.045
Apertura
25.830
Precio medio ponderado por volumen
25.83
Volumen
1.34M
Capitalización
24.07B
Mínimo
25.720
Importe
34.58M
EV/EBITDA, TTM
7.95

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

www.philips.com

Análisis de IA of Koninklijke Philips NV (PHG)

Comprar

Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.

Recomendaciones de analistas (1)

Comprar
1 Comprar
0 Mantener
0 Vender
Actual: 25.74
Mínimo
—
Promedio
—
Máximo
—

Morgan Stanley

2026-09-11

Precio objetivo

—

Equal Weight

UBS

2026-08-03

Precio objetivo

—

Neutral

Deutsche Bank

2026-07-30

Precio objetivo

—

Mantener

JPMorgan

2026-07-29

Precio objetivo

—

Neutral

Citi

2026-07-01

Precio objetivo

—

Neutral

Métricas de valoración

El PER previsto actual de Koninklijke Philips NV (PHG) es 12.72, frente a su media de 5 años de 15.46.

PER previsto

Valor razonable
Media 5A P/E
15.46
P/E actual
12.72
Sobrevalorada
21.26
Infravalorada
9.66

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
9.42
EV/EBITDA actual
7.95
Sobrevalorada
11.43
Infravalorada
7.40

Precio/ventas previsto

Valor razonable
Media 5A P/S
1.15
P/S actual
1.33
Sobrevalorada
1.43
Infravalorada
0.87

Escenarios de precio de Alphio AI para PHG

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%PHG

$30.22

Precio del escenario

B

Base

Base · 50%PHG

$25.07

Precio del escenario

B

Bajista

Bajista · 25%PHG

$24.03

Precio del escenario

Ballenas con PHG en cartera

L

Lingotto Investment Management LLP

+ Con en carteraPHG

+24.44%

Rentabilidad a 3 meses

W

W1M Asset Management Limited

+ Con en carteraPHG

+5.30%

Rentabilidad a 3 meses

B

Becker Capital Management Inc

+ Con en carteraPHG

+4.53%

Rentabilidad a 3 meses

M

Mondrian Investment Partners Limited

+ Con en carteraPHG

+2.68%

Rentabilidad a 3 meses

B

Bestinver Gestión, S.A. SGIIC

+ Con en carteraPHG

+1.76%

Rentabilidad a 3 meses

Cronología de eventos

2026-10-08 (ET)

09:30:00

Royal Philips Forms Global Clinical Advisory Board

2026-10-05 (ET)

09:30:00

Royal Philips Launches Sonicare 9900 Toothbrush at $379.99

2026-09-17 (ET)

09:30:00

Philips Installs First Rembra CT System in the U.S.

2026-08-11 (ET)

06:00:00

Philips and Exor Update Long-Term Relationship Agreement

Noticias

Preguntas frecuentes sobre PHG, respondidas por Alphio AI

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.

Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.

1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar